Shingo Omura

Shingo Omura, CFA, is a Director in the Investments Group and Senior Analyst at Brandes Investment Partners in San Diego, where he leads the Health Care Research Team with a primary focus on the global pharmaceutical sector. He is also a member of the International Large-Cap Investment Committee, serves as the primary Product Coordinator for the Japan Equity strategy, and participates actively on the firm’s Corporate Governance and Proxy Voting Committee, reflecting broad responsibility across international equity markets.

Prior to joining Brandes in 2005, Omura was a sell-side research analyst in Japan covering basic materials and utilities companies at Mizuho Securities, and earlier worked as a corporate banker at The Industrial Bank of Japan, gaining experience in diverse financial sectors. His earlier roles underpin his expertise in both equity research and corporate finance, with operational knowledge extending across Asian and global financial markets.

Omura holds an MBA from the University of California, Berkeley’s Haas School of Business, and a BA in Economics from Keio University in Tokyo. Noted for his analytical rigor and sector specialization, he is recognized as a limited partner of Brandes’ parent company and has played key roles in advancing the firm’s research and investment oversight practices, particularly in healthcare, Japanese equities, and corporate governance.